Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention
1 other identifier
interventional
80
1 country
1
Brief Summary
This study will develop and pilot test a couples-based intervention to help adolescent girls and young women living with HIV (WLHIV (15-24 years) living in Uganda access HIV care and improve the outcomes of their HIV treatment by targeting male partner alcohol use to reduce IPV risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2023
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedFirst Posted
Study publicly available on registry
July 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
December 26, 2025
August 1, 2025
3.3 years
March 22, 2023
December 23, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
change from baseline in antiretroviral therapy (ART) adherence biomarker (females and HIV+ male partners)
presence of Tenofoivir Disoproxil Fumarate (TDF) detected in urine
3 and 6 month follow up
change from baseline in self-reported antiretroviral therapy (ART) adherence (females and HIV+ male partners)
Self- report of missed ART using the AIDS Clinical Trials Group Adherence (AACTG) measures
3 and 6 month follow up
change from baseline in HIV care engagement (females and HIV+ male partners)
HIV clinic visit adherence
3 months, 6 months
change from baseline in phosphatidylethanol (PEth) (male partners)
alcohol biomarker (PEth) levels
6 months
change from baseline in heavy drinking (male partners)
assessed with the Alcohol Use Disorders Identification Test (AUDIT-C)
3 months, 6 months
Intimate partner violence (IPV) occurence (males and females)
Any incident of IPV perpetration and victimization: physical, sexual, verbal/emotional, intimidation and/or controlling behavior measured using the World Health Organization (WHO) Instrument/ Demographic and Health Data (DHS) Domestic Violence Modules.
6 months
Secondary Outcomes (1)
Fear of intimate partner violence (males and females)
6 month follow up
Other Outcomes (3)
change from baseline in HIV viral load (females and HIV+ males)
6 months
change from baseline in PrEP adherence (male partners taking PrEP)
3 and 6 month follow up
PrEP uptake
through 6 month follow-up
Study Arms (2)
Kisoboka Mukwano Intervention (treatment)
EXPERIMENTALA brief couples-based intervention using motivational interviewing, peer navigation, and behavioral economic approaches to target intimate partner violence, alcohol use, and HIV care engagement.
Screening & Referral (control)
ACTIVE COMPARATORBrief feedback on intimate partner violence and alcohol use (males), referrals for these conditions, and briefly discuss the importance of HIV care engagement and adherence.
Interventions
The intervention consists of 5 bi-weekly sessions each lasting 60 to 90 minutes. It uses motivational interviewing, peer navigation, and behavioral economics to promote strategies for economic strengthening, reductions in male partner alcohol use, coping with relationship conflict and stress, changing norms that reduce intimate partner violence and support engagement in HIV care and antiretroviral therapy (ART) adherence among adolescent girls and young women living with HIV, and, thereby, enhances future sustained viral suppression and benefits of treatment as prevention.
Intimate partner violence screening, alcohol screening, and referral
Eligibility Criteria
You may qualify if:
- Adolescent girls and young women (AGYW)/Female:
- aged 18-24 or self-reported as emancipated minors aged 15-17,
- HIV+
- meets one or more of the following non-engagement criteria: not currently enrolled in an HIV clinic (e.g., never enrolled, dropped out); not currently taking ART; missed 1 or more scheduled HIV care appointments requiring physical presence (e.g., viral load \[VL\] testing) in the last 12 months; \< 90% ART adherence in the last 2 weeks; most recent VL\>1000 or expected recent VL test results absent in clinic records despite initiating ART \>6 months ago
- self-report a history of at least one incident of IPV (physical, sexual, and/or emotional) and/or controlling behavior ever perpetrated by their current male partner
- agree to let research staff contact their male partner.
- Male Partners of AGYW/Male:
- aged 18+ years or emancipated minors
- report consuming ≥ 6 drinks per occasion at least once or more in the prior 30 days or scores 4 or more on the AUDIT (Alcohol Use Disorders Identification Test)-C
- Couples (each partner (male and female) must independently report):
- married or living together as if married for ≥6 months
- planning to stay together for at least another 2 months (intervention period)
- lived in the Wakiso District area ≥3 months
- not planning to move from the area within the next 6 months
- respond similarly (not exact but close) to questions on the study-developed Couple Verification Screening
You may not qualify if:
- AGYW (female):
- reporting any severe physical IPV experienced in prior 3 months.
- Couples (male and female):
- do not speak Luganda or English
- do not feel they cannot safely participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arizona State Universitylead
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)collaborator
- San Diego State Universitycollaborator
- Makerere Universitycollaborator
- University of California, San Diegocollaborator
- Reach the Youth Ugandacollaborator
Study Sites (1)
Makerere Univerisity School of Public Health
Kampala, Uganda
Related Publications (1)
Nwabuzor Ogbonnaya I, Nakigudde J, Naigino R, Stockman JK, Chung Y, Nantongo M, Marsiglia FF, Hahn JA, Wechsberg WM, Mwebembezi A, Wanyenze RK, Kiene SM. Protocol for the Kisoboka Mukwano pilot randomized controlled trial in Uganda: A couples-based intervention to reduce intimate partner violence and alcohol use among adolescent girls and young women living with HIV and their male partners. Contemp Clin Trials. 2025 Dec;159:108136. doi: 10.1016/j.cct.2025.108136. Epub 2025 Nov 7.
PMID: 41207472DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ijeoma Nwabuzor Ogbonnaya, PhD
Arizona State University
- PRINCIPAL INVESTIGATOR
Susan M Kiene, PhD
San Diego State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 22, 2023
First Posted
July 17, 2023
Study Start
July 1, 2023
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
December 26, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ANALYTIC CODE
- Time Frame
- Two years after the grant end date specified on the first Notice of Award (08-31-2025). Any subject-level data and the associated analyzed data used in a journal publication will be shared at the time of publication, even if the publication occurs before the two-year automatic share date.
- Access Criteria
- Access to data for research purposes will be provided through the National Institute of Mental Health (NIMH) Data Archive (NDA) Data Access Committee (DAC). Investigators and institutions seeking data from NDA will be expected to meet data security measures and will be asked to submit a Data Use Certification, which is cosigned by the investigator and the designated Institutional Official(s) at the NIH-recognized sponsoring institution with a current Federal Wide Assurance (FWA).
All collected individual participant data (IPD) that underlie the 6-month clinical trial, excluding qualitative data and data collected for formative research.